Nasdaq (NDAQ) Earnings Analysis
Nasdaq (NDAQ) has no confirmed upcoming earnings date. Last quarter (2026-07-23) it beat with EPS 1.07 USD vs 0.984 USD est (+8.7%). It has beaten estimates in 8/8 recent quarters (100%). Trailing P/E 27.05.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does NDAQ next report earnings?
No confirmed upcoming earnings date is currently scheduled for NDAQ. This page updates as the calendar is published.
NDAQ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-07-23 | 1.07 USD | 0.984 USD | +8.7% | Beat |
| 2026-04-23 | 0.96 USD | 0.93 USD | +3.2% | Beat |
| 2026-01-29 | 0.96 USD | 0.922 USD | +4.1% | Beat |
| 2025-10-21 | 0.88 USD | 0.852 USD | +3.3% | Beat |
| 2025-07-24 | 0.85 USD | 0.814 USD | +4.4% | Beat |
| 2025-04-24 | 0.79 USD | 0.771 USD | +2.5% | Beat |
| 2025-01-29 | 0.76 USD | 0.74 USD | +2.7% | Beat |
| 2024-10-24 | 0.74 USD | 0.694 USD | +6.6% | Beat |
Beat rate: 8/8 (100%) over reported quarters with consensus data.
NDAQ valuation and analyst view
| Trailing P/E | 27.05 |
|---|---|
| Trailing EPS | 3.375 USD |
| Price / book | 4.28 |
| Dividend yield | 1.23% |
| Market cap | 51.54B |
| Analyst consensus | Buy (22 buy / 13 hold / 1 sell) |
| Avg price target | 112 USD |
Related research pages
Frequently asked questions
When is Nasdaq (NDAQ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for NDAQ. This page updates as the calendar is published.
Did NDAQ beat earnings last quarter?
In its 2026-07-23 report, NDAQ posted EPS of 1.07 USD versus a 0.984 USD estimate — a beat of 8.7%.
What is NDAQ's earnings track record?
Over the last 8 reported quarters with consensus data, NDAQ beat estimates 8 times (100%).
What is NDAQ's current P/E ratio and EPS?
NDAQ trades at a trailing P/E of 27.05 on trailing EPS of 3.375088214537756 USD.
What do analysts rate NDAQ?
Analyst consensus is "Buy" across 36 ratings (0 strong buy, 22 buy, 13 hold, 1 sell, 0 strong sell). Average 12-month price target: 112 USD.